How BerGenBio became a frontrunner in UK hunt for Covid-19 treatment
Norwegian biopharma firm BerGenBio is the first of six companies to have its potential Covid-19...
BerGenBio reports positive results from first stage of NSCLC study
Norwegian biopharmaceutical company BerGenBio has reported positive results from the first stage of a Phase...
Deals this week: Trevena, Compugen, Biohaven Pharmaceutical
Trevena plans to raise $175m through a public offering of securities.
Deals this week: Aeglea BioTherapeutics, BerGenBio, Evelo Biosciences
Aeglea BioTherapeutics intends to raise funds for its ongoing research and development (R&D), production and...